Publications

Baudic, S., Barba, G., Thibaudet, M., Smagghe, A., Remy, P. & Traykov, L. (2006). Executive function deficits in early Alzheimer's disease and their relations with episodic memory. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 21(1), 15-21. doi:10.1016/j.acn.2005.07.002

Drouot, X., Oshino, S., Jarraya, B., Besret, L., Kishima, H., Remy, P., Dauguet, J., Lefaucheur, J., Dollé, F., Condé, F., Bottlaender, M., Peschanski, M., Keravel, Y., Hantraye, P. & Palfi, S. (2004). Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. Neuron, 44(5), 769-78. doi:10.1016/j.neuron.2004.11.023

Payoux, P., Remy, P., Damier, P., Miloudi, M., Loubinoux, I., Pidoux, B., Gaura, V., Rascol, O., Samson, Y. & Agid, Y. (2004). Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Archives of neurology, 61(8), 1307-13. doi:10.1001/archneur.61.8.1307

Whone, A., Bailey, D., Remy, P., Pavese, N. & Brooks, D. (2004). A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45(7), 1135-45.

Remy, P. & Samson, Y. (2003). The role of dopamine in cognition: evidence from functional imaging studies. Current opinion in neurology, 16 Suppl 2, S37-41.

Gaura, V., Bachoud-Levi, A., Ribeiro, M., Nguyen, J., Frouin, V., Baudic, S., Brugières, P., Mangin, J., Boissé, M., Palfi, S., Cesaro, P., Samson, Y., Hantraye, P., Peschanski, M. & Remy, P. (2004). Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain : a journal of neurology, 127(Pt 1), 65-72. doi:10.1093/brain/awh003

Cochen, V., Ribeiro, M., Nguyen, J., Gurruchaga, J., Villafane, G., Loc'H, C., Defer, G., Samson, Y., Peschanski, M., Hantraye, P., Cesaro, P. & Remy, P. (2003). Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Movement disorders : official journal of the Movement Disorder Society, 18(8), 928-32. doi:10.1002/mds.10463

Whone, A., Watts, R., Stoessl, A., Davis, M., Reske, S., Nahmias, C., Lang, A., Rascol, O., Ribeiro, M., Remy, P., Poewe, W., Hauser, R., Brooks, D. & Real-Pet Study, G. (2003). Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Annals of neurology, 54(1), 93-101. doi:10.1002/ana.10609

Thobois, S., Ribeiro, M., Lohmann, E., Durr, A., Pollak, P., Rascol, O., Guillouet, S., Chapoy, E., Costes, N., Agid, Y., Remy, P., Brice, A., Broussolle, E. & French Parkinson'S Disease Genetics Study, G. (2003). Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study. Archives of neurology, 60(5), 713-8. doi:10.1001/archneur.60.5.713

Bachoud-Levi, A., Gaura, V., Brugières, P., Lefaucheur, J., Boissé, M., Maison, P., Baudic, S., Ribeiro, M., Bourdet, C., Remy, P., Cesaro, P., Hantraye, P. & Peschanski, M. (2006). Persistent benefit of foetal neural transplants in patients with Huntington's disease six years after surgery. Lancet Neurol(5 ), 303-309

Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. (2005). Decrease of dopamine and noradrenaline innervation in the limbic system of depressed Parkinson’s disease patients. Brain(128 ), 1314-1322

Bachoud-Levi, A., Remy, P., Brugières, P., Lefaucheur, J., Bourdet, C., Baudic, S., Gaura, V., Maison, P., Haddad , B., Boissé, M., Grandmougin , T., Jény , R., Bartolomeo, P., Dalla Barba , G., Degos, J., Lisovoski , F., Pailhous , E., Cesaro, P., Hantraye, P. & Peschanski, M. (2000). Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation. Lancet(356), 1975-1979

Salem, L., Saleh, N., Désaméricq, G., Youssov, K., Dolbeau, G., Cleret de Langavant, L., Bourhis, M., Azulay, J., Krystkowiak, P., Verny, C., Morin, F., Moutereau, S., French Huntington Study, G., Bachoud-Levi, A. & Maison, P. (2016). Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease. PloS one, 11(9), e0162890. doi:10.1371/journal.pone.0162890

Mariani, L., Tesson, C., Charles, P., Cazeneuve, C., Hahn, V., Youssov, K., Freeman, L., Grabli, D., Roze, E., Noël, S., Peuvion, J., Bachoud-Levi, A., Brice, A., Stevanin, G. & Durr, A. (2016). Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach. JAMA neurology, 73(9), 1105-14. doi:10.1001/jamaneurol.2016.2215

Rosser, A. & Bachoud-Levi, A. (2012). Clinical trials of neural transplantation in Huntington's disease. Progress in brain research, 200, 345-71. doi:10.1016/B978-0-444-59575-1.00016-8

De Diego-Balaguer, R., Couette, M., Dolbeau, G., Durr, A., Youssov, K. & Bachoud-Levi, A. (2008). Striatal degeneration impairs language learning: evidence from Huntington's disease. Brain - A Journal of Neurology . doi:10.1093/brain/awn242

Saleh, N., Moutereau, S., Azulay, J., Verny, C., Simonin, C., Tranchant, C., El Hawajri, N., Bachoud-Levi, A. & Maison, P. (2010). High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology. doi:10.1212/WNL.0b013e3181e62076

Gaura, V., Lavisse, S., Payoux, P., Goldman, S., Verny, C., Krystkowiak, P., Damier, P., Supiot, F., Bachoud-Levi, A. & Remy, P. (2017). Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease. JAMA neurology, 74(9), 1088-1096. doi:10.1001/jamaneurol.2017.1200

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & Cyst-Hd Study, G. (2017). A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 32(6), 932-936. doi:10.1002/mds.27010

Van Der Gucht, A., Aoun Sebaiti, M., Guedj, E., Aouizerate, J., Yara, S., Gherardi, R., Evangelista, E., Chalaye, J., Cottereau, A., Verger, A., Bachoud-Levi, A., Abulizi, M., Itti, E. & Authier, F. (2017). Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 58(3), 492-498. doi:10.2967/jnumed.114.151878

Van Der Gucht, A., Aoun-Sebaiti, M., Kauv, P., Guedj, E., Aouizerate, J., Verger, A., Gherardi, R., Bachoud-Levi, A., Authier, F. & Itti, E. (2016). FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis. Nuclear medicine and molecular imaging, 50(1), 80-4. doi:10.1007/s13139-015-0371-z

Schramm, C., Vial, C., Bachoud-Levi, A. & Katsahian, S. (2015). Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data. Statistical methods in medical research, 27(1), 97-113. doi:10.1177/0962280215621591

Désaméricq, G., Youssov, K., Charles, P., Saleh, N., Olivier, A., Sherer-Gagou, C. & Verny, C. (2016). Guidelines for clinical pharmacological practices in Huntington's disease. Rev Neurol (Paris), 172(8-9), 423-432. doi:10.1016/j.neurol.2016.07.012

Cubo, E., Ramos-Arroyo, M., Martinez-Horta, S., Martínez-Descalls, A., Calvo, S., Gil-Polo, C. & European Hd, N. (2016). Clinical manifestations of intermediate allele carriers in Huntington disease. Neurology, 87(6), 571-8. doi:10.1212/WNL.0000000000002944

De Diego-Balaguer, R., Rodríguez-Fornells, A. & Bachoud-Levi, A. (2015). Prosodic cues enhance rule learning by changing speech segmentation mechanisms. Frontiers in psychology, 6, 1478. doi:10.3389/fpsyg.2015.01478

Simonin, C., Duru, C., Salleron, J., Hincker, P., Charles, P., Delval, A., Youssov, K., Burnouf, S., Azulay, J., Verny, C., Scherer, C., Tranchant, C., Goizet, C., Debruxelles, S., Defebvre, L., Sablonnière, B., Romon-Rousseaux, M., Buée, L., Destée, A., Godefroy, O., Durr, A., Landwehrmeyer, B., Registry Study Of The European Huntington'S Disease, N., Bachoud-Levi, A., Richard, F., Blum, D., Krystkowiak, P. & Huntington French Speaking, N. (2013). Association between caffeine intake and age at onset in Huntington's disease. Neurobiology of disease, 58, 179-82. doi:10.1016/j.nbd.2013.05.013

Bartolomeo, P., Bachoud-Levi, A. & De Schotten, T. (2014). The anatomy of cerebral achromatopsia: a reappraisal and comparison of two case reports. Cortex, 56, 138-44. doi:10.1016/j.cortex.2013.01.013

Dulin, D., Cavezian, C., Serrière, C., Bachoud-Levi, A., Bartolomeo, P. & Chokron, S. (2011). Colour, face, and visuospatial imagery abilities in low-vision individuals with visual field deficits. Quarterly journal of experimental psychology (2006), 64(10), 1955-70. doi:10.1080/17470218.2011.608852

Bachoud-Levi, A. (2009). Neural grafts in Huntington's disease: viability after 10 years. The Lancet. Neurology, 8(11), 979-81. doi:10.1016/S1474-4422(09)70278-9

Lefaucheur, J., Ménard-Lefaucheur, I., Maison, P., Baudic, S., Cesaro, P., Peschanski, M. & Bachoud-Levi, A. (2006). Electrophysiological deterioration over time in patients with Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 21(9), 1350-4. doi:10.1002/mds.20966